1996

Chapter II has described the main elements of the policy framework for innovation and access. This chapter considers how this policy framework applies to innovation in medical technologies. It reviews the factors that have spurred innovation in medical technologies in the past, identifies how current models of R&D are evolving, and charts the role of established and new participants in the innovation process, including in the context of neglected diseases, emerging pathogens with pandemic potential and antibacterial treatments. It also covers the role of IP, particularly patents, in the R&D system.

Related Topics: Intellectual property
/content/books/9789287049971c007
dcterms_subject,pub_countryId
-contentType:WorkingPaperSeries -contentType:Periodical -contentType:BookSeries -contentType:ReportSeries
10
5
Este es un campo obligatorio
Por favor, introduce una dirección de correo electrónico válida
La aprobación fue un éxito
Datos inválidos
Ocurrió un error
La aprobación fue parcialmente exitosa, los siguientes elementos seleccionados no se pudieron procesar debido a un error
aHR0cHM6Ly93d3cud3RvLWlsaWJyYXJ5Lm9yZy8K